17th JPIAMR transnational call for research projects - AMR Interventions 2024 (IMPACT)

General Information

• Type: Partner looking for project
• Organisation: Microviable Therapeutics SL
• Country: Spain (ES)
• Career stage: Early Career Researcher (up to 8 years** since PhD).

Research area

• Scientific area(s) of the call:
  1. Topic 2: Improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.
• Subtopics:
  1. Improve and/or compare and/ or evaluate the effectiveness of existing interventions (e.g. cost effectiveness clinical utility, socio-economic adaptability, reducing AMR emergence, spread, transmission, treatment etc.)

• One Health Setting:

  Human Health

• Keywords:

  Microbiome-based therapies; microbiota; purified microbiota;

• Brief description of your expertise / expertise you are looking for:

  Microviable´s mission is to develop novel biological drugs and personalized therapies to address unmet challenges in human diseases providing innovative solutions based on the microbiota. Microviable´s team has expertise in integrated microbiome projects, handling of extremely sensitive to oxygen bacteria and metabolic, techologic and immunogenic characterization of bacterial strai

• Brief description of your project / the project you would like to join:

  Microviable’s PharmaBiota® platform enabled the creation of a large and diverse bacterial strain collection with thousands of isolates to generate a second category of biological products based on our fully integrated R&D capabilities. In addition, our product MVT-201, consisting in a purified microbiota has shown promising results against multirresistant bacteria in preclinical studies. We are looking for partners interested in using our colleciton of bacteria or our product MVT-201 in a clinical trial.

David Ríos Covián

• Organisation: Microviable Therapeutics SL
• Position: Director of Technology Development
• E-mail: david.rios@microviable.com
• Phone: 984088384
• Web: www.microviable.com/en/home-2/